Trial intelligence / Profile preview

Esketamine vs sufentanil with propofol for painless gastroenteroscopy in elderly patients

ChiCTR2400088855Phase 4Not yet recruiting

Sponsor
Beijing Friendship Hospital
Start
Aug 2024
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in hypotension comparing Group A: esketamine + propofol with Group B: sufentanil + propofol (2 arms). Primary endpoint: Incidence of hypotension. Planned start Aug 2024; status: not yet recruiting.

02

Drugs

esketaminesufentanilpropofol
03

Conditions

hypotension

Beyond the preview

Go deeper on ChiCTR2400088855.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400088855.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call